Cyclic D-Sulfopeptide Ligands Lend Drug Development a Helping Hand
Posted by Francis Peterson on 4/2/2026 to
Literature Highlights
In their recent paper, Zhang and colleagues identified a 24-residue cyclic D –sulfopeptide inhibitor of CCL22, a chemokine associated with allergenic inflammation and atopic dermatitis.
